During cancer treatment, the word immunity comes up constantly, and after hearing that your white cell count has dropped it is natural to wonder whether a hospital can prescribe something to strengthen it. In clinical practice, however, there is no single drug that raises immunity in general. Instead there are several distinct categories of prescriptions with different goals, and the indication, cost coverage, and realistic expectation differ completely depending on which category is involved. Asking what you are trying to prevent or support right now usually leads to a clearer answer than asking for a list of available drugs.
The first category is immune checkpoint inhibitors, often called immunotherapy. Despite the name, these are treatments rather than supplements: they release the brakes on immune cells so they can recognize tumor cells, and eligibility depends on cancer type, stage, and biomarker results such as PD-L1 or MSI status. Because they change the treatment plan itself, it is worth asking whether your team has already considered them.
The second category addresses low blood counts. Granulocyte colony-stimulating factor (G-CSF) is given when neutrophils fall after chemotherapy, and erythropoiesis-stimulating agents or transfusion may be used for anemia. These are not general immune boosters; their purpose is to shorten the window of high infection risk so that scheduled treatment can continue on time. Timing and reimbursement criteria are fairly specific, so they are not prescribed simply on request.
The third category is infection prevention: influenza and pneumococcal vaccination given at the right time, prophylaxis against Pneumocystis pneumonia during prolonged steroid or certain chemotherapy regimens, and antivirals to prevent shingles or hepatitis B reactivation. Intravenous immunoglobulin (IVIG) is reserved for documented antibody deficiency in specific conditions rather than for general fatigue or weakness.
A fourth category includes complementary injections offered at some centers outside standard insurance coverage, such as mistletoe extract, generally aimed at symptoms and quality of life. Evidence for prolonging survival remains limited. If such an option is offered, ask in the same visit about its purpose, cost, compatibility with your current regimen, and who manages any side effects.
The fifth is correcting deficiency. Low protein and calorie intake, or confirmed low vitamin D, iron, or zinc, are legitimate targets for treatment. Correcting a deficiency is not the same as adding more to a normal level, and high-dose antioxidant supplements or injections of unclear composition may interfere with treatment or liver and kidney values, so disclose everything you take.
Useful questions include: given my counts, is there a vaccine or preventive medication I should have now? If neutrophils drop again next cycle, would you use growth factor or adjust the dose? Does anything on my supplement list conflict with my treatment? Is this injection covered, and is its goal symptom relief or cancer control?
One order should never be reversed: no supportive prescription replaces the response to fever. A temperature of 38C or higher, chills, sudden breathlessness, or confusion during chemotherapy may be an emergency during low-count periods, so contact your team or emergency department before covering the fever with antipyretics.
This article is general information and does not replace medical care. What applies to you depends on your cancer type, stage, laboratory results, and current medications, so please discuss any decision with your own healthcare team.